These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30941143)

  • 21. RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities.
    Rai R; Chauhan SK; Singh VV; Rai M; Rai G
    PLoS One; 2016; 11(11):e0166312. PubMed ID: 27835693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases.
    Sulcebe G; Morcka K
    Clin Exp Rheumatol; 1992; 10(3):255-61. PubMed ID: 1582070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The intrathecal polyspecific antiviral immune response (MRZ reaction): A potential cerebrospinal fluid marker for multiple sclerosis diagnosis.
    Feki S; Gargouri S; Mejdoub S; Dammak M; Hachicha H; Hadiji O; Feki L; Hammami A; Mhiri C; Karray H; Masmoudi H
    J Neuroimmunol; 2018 Aug; 321():66-71. PubMed ID: 29957390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parvovirus B19 and mumps virus antibodies are major constituents of the intrathecal immune response in European patients with MS and increase the diagnostic sensitivity and discriminatory power of the MRZ reaction.
    Jarius S; Wilken D; Haas J; Ruprecht K; Komorowski L; Wildemann B
    J Neurol; 2021 Oct; 268(10):3758-3765. PubMed ID: 33770235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
    Tipu HN; Bashir MM
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
    Homburger HA; Cahen YD; Griffiths J; Jacob GL
    Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results.
    Bonaguri C; Melegari A; Ballabio A; Parmeggiani M; Russo A; Battistelli L; Aloe R; Trenti T; Lippi G
    Autoimmun Rev; 2011 Nov; 11(1):1-5. PubMed ID: 21741498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance and prognostic value of serum autoantibody tests in multiple sclerosis.
    Öncel S; Şule Dalkılıç Ş; Sayan S; Darol E; Zafer A; Kara D; Tunç A
    Neurol Neurochir Pol; 2024; 58(1):60-65. PubMed ID: 37466321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies.
    Kang I; Siperstein R; Quan T; Breitenstein ML
    Clin Rheumatol; 2004 Dec; 23(6):509-15. PubMed ID: 15801070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging technologies in autoantibody testing for rheumatic diseases.
    Olsen NJ; Choi MY; Fritzler MJ
    Arthritis Res Ther; 2017 Jul; 19(1):172. PubMed ID: 28738887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antinuclear antibodies positivity is not rare during multiple sclerosis and is associated with relapsing status and IgG oligoclonal bands positivity.
    Mejdoub S; Feki S; Farhat N; Dammak M; Hachicha H; Sakka S; Ayedi A; Ayedi F; Mhiri C; Masmoudi H
    Rev Neurol (Paris); 2022 Oct; 178(8):812-816. PubMed ID: 35589445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiac abnormalities in patients with systemic lupus erythematosus: the role of antiphospholipid antibodies].
    Monti M; Borgognoni F; Pastacci L; Vincentelli GM
    G Ital Cardiol (Rome); 2016 Dec; 17(12):1001-1007. PubMed ID: 28151504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of linear discriminant analysis in performance evaluation of extractable nuclear antigen immunoassay systems in the screening and diagnosis of systemic autoimmune rheumatic diseases.
    Pi D; de Badyn MH; Nimmo M; White R; Pal J; Wong P; Phoon C; O'Connor D; Pi S; Shojania K
    Am J Clin Pathol; 2012 Oct; 138(4):596-603. PubMed ID: 23010715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antinuclear antibody testing in pleural fluid for the diagnosis of lupus pleuritis.
    Porcel JM; Ordi-Ros J; Esquerda A; Vives M; Madroñero AB; Bielsa S; Vilardell-Tarrés M; Light RW
    Lupus; 2007; 16(1):25-7. PubMed ID: 17283581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction.
    Vlad B; Neidhart S; Hilty M; Ziegler M; Jelcic I
    Front Neurol; 2023; 14():1135392. PubMed ID: 37034091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
    Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
    Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
    Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
    Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modelling autoimmune rheumatic disease: a likelihood rationale.
    Ulvestad E
    Scand J Immunol; 2003 Jul; 58(1):106-11. PubMed ID: 12828565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.